Your browser doesn't support javascript.
loading
Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson's disease and atypical Parkinsonian syndromes.
Schröter, Nils; van Eimeren, Thilo; Classen, Joseph; Levin, Johannes; Redecker, Christoph; Wolz, Martin; Tönges, Lars.
Afiliação
  • Schröter N; Department of Neurology and Clinical Neuroscience, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany. Nils.Schroeter@uniklinik-freiburg.de.
  • van Eimeren T; Department of Neurology, Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Classen J; Department of Neurology, University of Leipzig, Leipzig, Germany.
  • Levin J; Department of Neurology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Redecker C; German Center for Neurodegenerative Diseases, Site Munich, Munich, Germany.
  • Wolz M; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Tönges L; Department of Neurology, Lippe General Hospital, Lemgo, Germany.
J Neural Transm (Vienna) ; 130(6): 839-846, 2023 06.
Article em En | MEDLINE | ID: mdl-37046147
ABSTRACT
The clinical presentation of Parkinson's disease and atypical Parkinsonian syndromes is often heterogeneous. Additional diagnostic procedures including brain imaging and biomarker analyses can help to appreciate the various syndromes, but a precise clinical evaluation and differentiation is always necessary. To better assess the relevance of distinct clinical symptoms that arose within 1 year of disease manifestation and evaluate their indicative potential for an atypical Parkinsonian syndrome, we conducted a modified Delphi panel with seven movement disorder specialists. Five different topics with several clinical symptom items were discussed and consensus criteria were tested. This resulted in distinct symptom patterns for each atypical Parkinsonian syndrome showing the multitude of clinical involvement in each neurodegenerative disease. Strongly discriminating clinical signs were few and levels of indication were variable. A prospective validation of the assessments made is needed. This demonstrates that both clinical evaluation and elaborate additional diagnostic procedures are needed to achieve a high diagnostic standard.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Paralisia Supranuclear Progressiva / Atrofia de Múltiplos Sistemas / Transtornos Parkinsonianos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Neural Transm (Vienna) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Paralisia Supranuclear Progressiva / Atrofia de Múltiplos Sistemas / Transtornos Parkinsonianos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Neural Transm (Vienna) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha